Sjogren’S Disease
Exposure to nitrogen oxides, particulate matter increase risk for autoimmune disease
Exposure to various air pollutants, such as PM2.5 and nitrogen oxides, increases the risk for several autoimmune diseases, including psoriasis, lupus and rheumatoid arthritis, according to data published in Scientific Reports.
Potential Sjögren’s drugs may herald ‘paradigm shift’ to treating underlying processes
Clinical trial results in Sjögren’s disease over the last decade have volleyed between encouraging successes and deflating failures, but with several new drugs advancing through the pipeline, hopes are high yet again.
Nipocalimab bests placebo, ‘justifies further development’ in Sjögren’s disease
WASHINGTON — A 15 mg/kg dose of the neonatal fragment crystallizable receptor blocker nipocalimab outperformed placebo in improving Sjögren’s disease activity at 24 weeks, according to data presented at ACR Convergence 2024.
IV nipocalimab reduces disease expression in generalized myasthenia gravis
Treatment with IV nipocalimab was safe and led to significant reductions in disease expression at 24 weeks in adolescents with generalized myasthenia gravis, according to data presented at AANEM.
‘My own diagnosis was delayed’: Sjögren’s myths overshadow multi-system manifestations
Despite being one of the most prevalent autoimmune diseases in the United States, Sjögren’s disease remains shrouded behind significant misconceptions and knowledge gaps that can delay diagnosis and appropriate treatment.
Best rheumatology Q&As of 2023 covered Alzheimer’s, lupus in a catatonic patient
In 2023, Healio had questions, the experts had answers.